Price Alert

Chugai Pharmaceutical Co.... (CHGCY)

OTC: CHGCY · Real-Time Price · USD

21.28

0.49 (2.36%)

At close: Aug 15, 2025, 3:59 PM

21.25

-0.12%

After-hours: Aug 15, 2025, 04:00 PM EDT

Chugai Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	393.76B	462.86B	458.67B	331.34B	365.02B	247.69B	222.17B	274.04B	360.31B	230.47B	267.75B	192.52B	187.13B	162.05B
Short-Term Investments	421.9B	301.7B	280.31B	287.42B	299.97B	306.93B	280.94B	271.25B	231.93B	201.35B	204.22B	204.13B	204.1B	181.32B
Long-Term Investments	n/a	65.42B	1.25B	4.83B	4.9B	61.52B	-279.1B	-269.43B	-229.62B	-198.96B	-201.82B	-201.45B	-201.22B	-178.63B
Other Long-Term Assets	133.55B	n/a	59.83B	52.44B	58.2B	n/a	335.29B	317.9B	273.24B	242.04B	246.49B	232.86B	231.9B	210.27B
Receivables	349.66B	239.67B	318.89B	315.63B	295.33B	360.99B	512.54B	274.66B	268.48B	390.57B	355.08B	292.44B	243.22B	190.71B
Inventory	265.7B	276.68B	273.48B	277.46B	266.4B	278.86B	292.21B	313.01B	218.47B	225.48B	208.84B	201.42B	199.16B	184.66B
Other Current Assets	45.01B	40.94B	13.24B	45.13B	46.11B	32.53B	9.92B	51.6B	47.33B	43.78B	10.47B	23.08B	23.51B	22.24B
Total Current Assets	1,476B	1,321.9B	1,366.4B	1,257B	1,272.8B	1,227B	1,336.5B	1,184.6B	1,126.5B	1,091.6B	1,063.7B	913.6B	857.12B	740.97B
Property-Plant & Equipment	430.23B	426.42B	420.7B	417.83B	405.76B	399.78B	386.65B	373.22B	366.91B	361.13B	352.11B	333.2B	316.87B	298.81B
Goodwill & Intangibles	20.35B	19.56B	19.86B	19.98B	20.69B	19.69B	25.14B	26.34B	25.52B	24.9B	21.97B	24.79B	25.27B	26.02B
Total Long-Term Assets	584.13B	575.91B	566.12B	560.67B	558.77B	544.99B	533.22B	516.25B	499.08B	493.3B	475.03B	439.77B	418.64B	403.66B
Total Assets	2,060.2B	1,897.8B	1,932.5B	1,817.6B	1,831.6B	1,772B	1,869.8B	1,700.8B	1,625.6B	1,584.9B	1,538.7B	1,353.4B	1,275.8B	1,144.6B
Account Payables	78.95B	88.72B	112.47B	112.38B	97.8B	166.17B	209.84B	188.22B	93.26B	153.07B	152.27B	138.26B	106.81B	61.57B
Deferred Revenue	n/a	n/a	31M	n/a	n/a	n/a	79M	n/a	n/a	n/a	86M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	138.5B	150.26B	131.12B	151.75B	200.66B	148.98B	176.06B	180.75B	201.18B	167.44B	140.65B	106.41B	99.1B	82.53B
Total Current Liabilities	290.14B	238.98B	288.22B	264.12B	298.46B	315.15B	423.73B	368.97B	294.44B	320.51B	327.42B	244.67B	205.91B	144.1B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	18.33B	16.74B	18.37B	18.53B	19.8B	19.9B	21.64B	23.23B	23.82B	23.92B	22.77B	18.05B	17.8B	17.92B
Total Long-Term Liabilities	18.33B	16.74B	18.75B	18.53B	19.8B	19.9B	21.64B	23.23B	23.82B	23.92B	23.25B	18.05B	17.8B	17.92B
Total Liabilities	308.47B	255.72B	306.97B	282.66B	318.27B	335.05B	445.37B	392.19B	318.26B	344.44B	350.68B	262.71B	223.71B	162.02B
Total Debt	6.58B	6.85B	13.46B	8.43B	7.59B	8.16B	14.11B	9.37B	9.25B	10.09B	16.04B	4.99B	4.73B	n/a
Common Stock	n/a	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B	73.2B
Retained Earnings	1,609.2B	1,497.3B	1,488.7B	1,395.7B	1,383.9B	1,300.7B	1,293.4B	1,187.9B	1,182.6B	1,110.2B	1,054B	954.61B	917.91B	847.19B
Comprehensive Income	-368M	2B	-5.71B	-3.11B	-12.91B	-6B	-10.97B	-21.16B	-17.07B	-11.41B	-7.46B	-5.24B	-7.02B	-5.6B
Shareholders Equity	1,751.7B	1,642B	1,625.6B	1,535B	1,513.3B	1,436.9B	1,424.4B	1,308.6B	1,307.3B	1,240.5B	1,188B	1,090.6B	1,052.1B	982.61B
Total Investments	421.9B	301.7B	281.56B	287.42B	299.97B	306.93B	1.84B	1.82B	2.31B	2.38B	2.39B	2.68B	2.88B	2.69B